ACCORD HEALTHCARE, UNIPESSOAL, LDA secures contract for General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents - 2023/0492 - POSACONAZOL [100 MG; CAP/ COMP]

Posted On: 2025-11-07

Portugal, Nov. 7 -- Portugal based ACCORD HEALTHCARE, UNIPESSOAL, LDA has secured contract from Unidade Local de Saude Santa Maria, E.P.E. for General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents - 2023/0492 - POSACONAZOL [100 MG; CAP/ COMP]. The value of the contract is worth 10571904 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

ACCORD HEALTHCARE, UNIPESSOAL, LDA secures contract for General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents - 2023/0492 - POSACONAZOL [100 MG; CAP/ COMP]